New mineral spray shows promise for faster wound healing

NCT ID NCT07617961

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study is testing a mineral-based spray called THERAVEX on 26 people with various wounds, including burns, pressure sores, and diabetic ulcers. The spray is used alongside standard wound care to see if it helps the skin heal better and faster. So far, it appears safe and may reduce swelling and improve tissue repair.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

THERAVEX Tissue Care Spray Plus (mineral-based topical spray)

What this could lead to

If successful, this spray could offer a safe, easy-to-use option to help heal wounds and burns faster, reducing pain and infection risk.

What could go wrong

This is a very small pilot study with only 26 people, so results may not apply to everyone. It is too early to know if it works better than standard care alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

burn chronic ulcer of skin decubitus ulcer Diabetic Foot injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Biointelligent Technology Syst

    RECRUITING

    Barcelona, 08009, Spain

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••